Analyst Ratings for Orphazyme (ORPH)

ORPH Rating Summary

ORPH Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ORPH
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $14.00 (+222.6%) * Over Last 12-Mos
Rating Score: 6.7 / 10   Percentile Rank: 69%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/21/2021 Guggenheim Yatin Suneja Downgrade Buy
(Sell)
N/A
(N/A)
7.33
(4.34)
-40.79% Details
3/30/2021 BofA Securities N/A Downgrade Underperform
(Neutral)
5.00
(N/A)
8.80
(4.34)
-50.68% Details
Like ORPH Ratings? Also take a look at CYTR, CRMD, DIDI, TEDU

ORPH Ratings News